Mice Model Market 2022 Opportunities, Competition from Opponents, Dynamics, Demand, Challenge and Risk and Forecast to 2028

Mice Model Market Outlook 2028
• The global mice model market was valued at US$ 1.5 Bn in 2020
• It is estimated to expand at a CAGR of 6.2% from 2021 to 2028
• The global mice model market is expected to reach the value of US$ 2.3 Bn by the end of 2028
Analysts' Viewpoint on Mice Model Market Scenario
Since COVID-19 is linked with potential damage to organ systems, stakeholders in the healthcare industry are increasing research to develop vaccines and therapeutic agents against acute respiratory diseases. In many cases, animal testing has proven to be unreliable. Hence, the FDA (Food and Drug Administration) is predicted to implement the Modernization Act that would lift the compulsion of animal testing. Alternatives such as bio-printed organ models and human biology-based test methods hold promising potentials to replace ineffective mice models, thus inhibiting market growth. Due to these reasons, participants in the mice model market should unlock revenue opportunities in necessary healthcare applications such as for drug discovery and development. Animal models have and are anticipated to play an important role in the characterization of the pathophysiology of diseases and associated mechanisms of injury.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Need for Speedy Cancer Treatment Fueling Demand for Mice Models
Increased research & development (R&D) in gene technology, fueled by the need of accurate and speedy treatment in the changing medical industry, is augmenting the growth of the global mice model market. The identification of genomic differences to predict drug response or drug resistance by patients can offer scope to design a personalized therapy tailored to the specific characteristics of a particular cancer. The Mouse Avatar and Co-clinical Trial concepts have the capability to transform the drug development and healthcare process.

Demand for Vaccines Against Respiratory Diseases Grows Prominent amid COVID-19 Pandemic
The future possibilities for of the outbreak of COVID-19-like pandemics has brought stakeholders in the mice model market under great scrutiny by healthcare organizations. The high risk of morbidity and mortality associated with potential infectious outbreaks in the upcoming decade has heightened the need for vaccines and promising therapeutic agents to improve patient quality of life.
Since severe acute respiratory diseases can exacerbate into pneumonia, participants in the mice model market are expected to work closely with the World Health Organization (WHO) to increase research in vaccines and other therapeutic agents. Efforts are being made to prevent incidences of acute respiratory distress syndrome in patients.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2085

Can Mice Model Testing Be Completely Eliminated from Healthcare Industry?
Rising concerns about animal use for research and teaching purposes has been raised in nearly every part of the world in the past few years. A large number of international social organizations, such as PETA (People for the Ethical Treatment of Animals), believe that animal studies teach nothing about the health of humans, as human reactions to medications and illnesses are completely different from the reactions of mice and other animals.
Due to these reasons, stakeholders in the mice model market should target their R&D capabilities toward necessary healthcare activities such as in modern drug discovery. Animal models play an instrumental role in the development of safe & effective treatments and cures for diseases and/or associated symptoms. Other applications include drug target identification & evaluation of novel therapeutic agents for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy.
Studies for Identifying Gene-specific Functions Surging in Mice Model Market
Mice have been one of the most important research tools for basic and applied research in biomedical sciences, and this trend is anticipated to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the possibility of exploring precise gene-specific functions and various molecular events in living organisms. Combining mice models with advanced imaging technologies offer unique opportunities to understand the etiology and pathophysiology of human diseases.
Moreover, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and health conditions. For instance, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia (APL) which was largely terminal.
Dynamic Functional Mice Models Hold Potentials to Treat Complex Lung Diseases
The global mice model market has witnessed the development of several mice models in the last decade. Advanced mice models not only increase applications, but also acceptability of these models for increasing the availability of treatment for complex diseases.
Researchers are creating dynamic functional mice models for lung injury repair. This model would help in understanding some of the most complex aspects of lung diseases, and would be used for testing new therapies. The development of such models is likely to boost growth for the mice model market growth and increase funding for biomedical research. Furthermore, large pharmaceutical companies are focusing on entering into partnerships with institutes or companies specializing in the development of these models, providing a new source of funding and revenue generation.
Mice Model Market: Overview
• According to Transparency Market Research's latest report on the global mice model market for the historical period 2017-2019 and forecast period 2021-2028, increase in demand for mice models in personalized medicine due to development of personalized in vivo analysis mice models is projected to boost the growth of the global market during the forecast period

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2085

Rise in Investment in Biomedical Research: Key Driver
• Investment in biomedical research is considered one of the most important indicators of a country's research landscape. In the past 10 years, biomedical research expenditure has increased manifold globally. Investment in biomedical research is rising in most parts of the world. However, a few developed countries such as the U.S. and the U.K. have shown a cut down in research expenditure. A significant percent of these investments is utilized in basic research based on animal models.
• Over 60% of the National Institute of Health (NIH) extramural funding involves animal-related research, of which majority is allotted for mice-related studies. Increase in funding for biomedical research is expected to boost the growth of the global mice model market over the next few years.
Surge in Number of Advanced Mice Models Offering Applicability and Acceptability: Major Driver
• The global mice model market has witnessed development of several mice models in the past few years. Advanced mice models not only increase the applications, but also acceptability of these models for complex diseases.
• Researchers at the Children's Hospital Los Angeles and The Saban Research Institute of CHLA created a dynamic functional mouse model for lung injury repair. This model would help in understanding some of the most complex aspects of lung disease and would be used for testing new therapies. Development of such models is likely to boost market growth and increase funding for biomedical research. Moreover, large pharmaceutical companies focus on entering into alliances with institutes or companies specializing in the development of these models, providing a new source of funding and revenue generation.
Rise in Concerns about Animal Use to Restrain Global Market
• Concerns about animal use for research and teaching purposes have been raised in nearly every part of the world in the past few years. Large number of international social organizations, such as PETA, believe that animal studies teach nothing about the health of humans because human reactions to illnesses and medications are completely different from the reactions of other animals.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2085

Mice Model Market: Competition Landscape
• This report profiles major players in the global mice model market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
• The global mice model market is highly fragmented, with the presence of a number of international as well as regional players
• Leading players operating in the global mice model market are
o Charles River Laboratories
o Crescendo Biologics Limited
o Deltagen, Inc.
o GenOway S.A.
o Harlan Laboratories, Inc.
o ImmunoGenes AG
o Taconic Biosciences, Inc.
o Lexicon Pharmaceuticals
o SAGE Labs
o The Jackson Laboratory
o Taconic Biosciences, Inc.
o TransGenic, Inc., among others

Trending Reports:
https://www.transparencymarketresearch.com/covid19-diagnostics-market.html

https://www.transparencymarketresearch.com/respiratory-humidification-market.html

Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.